Ukar Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.56 M
as on 24-10-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.33 Cr
as on 24-10-2024
- Revenue 74.42%
(FY 2023)
- Profit 31.57%
(FY 2023)
- Ebitda 56.39%
(FY 2023)
- Net Worth 34.02%
(FY 2023)
- Total Assets 110.14%
(FY 2023)
About Ukar Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.56 M.
The company currently has active open charges totaling ₹22.33 Cr.
Rahul Sarin and Rachna Sarin serve as directors at the Company.
- CIN/LLPIN
U74999DL2015PTC281716
- Company No.
281716
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ukar Healthcare Private Limited offer?
Ukar Healthcare Private Limited offers a wide range of products and services, including Medical & Surgical Clothing, OT Linen, Infusion Syringes & Supplies, Catheter, Cardiovascular Drugs & Medication, Cardiac Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Surgical & ICU Equipments, Ventilator Parts & Consumables.
Who are the key members and board of directors at Ukar Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Sarin  | Director | 01-Jun-2017 | Current |
| Rachna Sarin | Director | 18-Jun-2015 | Current |
Financial Performance of Ukar Healthcare.
Ukar Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.42% increase. The company also saw a substantial improvement in profitability, with a 31.57% increase in profit. The company's net worth Soared by an impressive increase of 34.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ukar Healthcare?
In 2023, Ukar Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jun 2024 | ₹2.50 Cr | Open |
Others Creation Date: 12 Jun 2024 | ₹2.50 Cr | Open |
Others Creation Date: 28 May 2024 | ₹3.00 Cr | Open |
How Many Employees Work at Ukar Healthcare?
Ukar Healthcare has a workforce of 49 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ukar Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ukar Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
